Brief: Pharming Announces European Medicines Agency (EMA) Validates Its Marketing Authorisation Application Under Accelerated Assessment For Leniolisib
28/10/2022 06:08
Oct 28 (Reuters) - Pharming Group NV PHAR.AS :
* PHARMING ANNOUNCES EUROPEAN MEDICINES AGENCY (EMA)
VALIDATES ITS
MARKETING AUTHORISATION APPLICATION UNDER ACCELERATED ASSESSMENT
FOR LENIOLISIB
* PHARMING GROUP NV - MARKETING AUTHORISATION IN EUROPEAN
ECONOMIC
AREA ANTICIPATED IN H1 2023
* PHARMING GROUP NV - ANNOUNCES TODAY THAT ITS MARKETING
AUTHORISATION APPLICATION (MAA) FOR LENIOLISIB HAS BEEN
VALIDATED FOR SCIENTIFIC EVALUATION UNDER AN ACCELERATED
ASSESSMENT BY EUROPEAN MEDICINES AGENCY'S (EMA) COMMITTEE FOR
MEDICINAL PRODUCTS FOR HUMAN USE
Source text for Eikon: ID:nCNWH5QNVa
Further company coverage: PHAR.AS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))